View in EDS

Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer.

Saved in:
Bibliographic Details
Title: Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer.
Authors: Tepetam H; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey. htepetam78@yahoo.com.tr., Varan MP; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Alomarı O; Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey., Yıldırım S; Department of Medical Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Gedik D; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Odabaş H; Department of Medical Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Yaprak G; Prof. Dr. İlhan Varank Training And Research Hospital, Istanbul, Turkey., Taşlıyurt Ö; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Gül ŞK; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey.
Source: BMC cancer [BMC Cancer] 2026 May 11; Vol. 26 (1). Date of Electronic Publication: 2026 May 11.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2407
DOI:10.1186/s12885-026-16160-6